Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
ASO Visual Abstract: Efficacy of Bidirectional Paclitaxel Plus Capecitabine or Nilotinib for Peritoneal Carcinomatosis: A Single-Institution Analysis of Two Phase II Clinical Trials.
Journal: Annals of surgical oncology
Published: February 07, 2026
Cisplatin Differentially Damages Mammalian Vestibular End Organs.
Journal: Ear and hearing
Published: December 31, 2025
Efficacy of Bidirectional Paclitaxel plus Capecitabine or Nilotinib for Peritoneal Carcinomatosis: A Single Institution Analysis of Two Phase II Clinical Trials.
Journal: Annals of surgical oncology
Published: September 24, 2025
Approaches to managing ototoxicity in the workplace.
Journal: International journal of audiology
Published: June 14, 2025
Roadmap to a Global Template for Implementation of Ototoxicity Management for Cancer Treatment.
Journal: Ear and hearing
Published: September 12, 2024
Macrophage depletion protects against cisplatin-induced ototoxicity and nephrotoxicity.
Journal: Science advances
Published: July 24, 2024
Macrophage Depletion Protects Against Cisplatin-Induced Ototoxicity and Nephrotoxicity.
Journal: bioRxiv : the preprint server for biology
Published: November 28, 2023
Hear and Now: Ongoing Clinical Trials to Prevent Drug-Induced Hearing Loss.
Journal: Annual review of pharmacology and toxicology
Published: August 10, 2023
Cholesteatoma Is Associated With Pediatric Progressive Sensorineural Hearing Loss.
Journal: Ear and hearing
Published: December 03, 2021
Showing 1-10 of 10
Last Updated: 09/26/2026